The Pharmaceutical Contract Research Organization industry on FinBizNet covers 1 listed company, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 1 |
|---|---|
| Combined market cap | ₹11,186 Cr |
| Median P/E (profitable companies) | 63.5 |
| Median return on equity | 11.6% |
| Companies with latest quarterly results | 1 of 1 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Sequent Scientific Ltd | ₹11,186 Cr | 63.5 | 11.6% | ₹988 Cr | ₹85 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 1 listed company in the Pharmaceutical Contract Research Organization industry: Sequent Scientific Ltd.
By market capitalisation, the largest Pharmaceutical Contract Research Organization companies are Sequent Scientific Ltd (₹11,186 Cr).
The 1 Pharmaceutical Contract Research Organization companies tracked on FinBizNet have a combined market capitalisation of about ₹11,186 Cr.
The median price-to-earnings ratio across 1 profitable Pharmaceutical Contract Research Organization companies is 63.5, and the median return on equity across the industry is 11.6%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical Contract Research Organization industry.